![Abbreviations: LMWH, low molecular weight heparins; UFH, unfractionated... | Download Scientific Diagram Abbreviations: LMWH, low molecular weight heparins; UFH, unfractionated... | Download Scientific Diagram](https://www.researchgate.net/profile/Marc-Righini/publication/26273667/figure/fig1/AS:601690709446665@1520465652139/Abbreviations-LMWH-low-molecular-weight-heparins-UFH-unfractionated-heparin.png)
Abbreviations: LMWH, low molecular weight heparins; UFH, unfractionated... | Download Scientific Diagram
![Table 1 from Monitoring unfractionated heparin with the aPTT: time for a fresh look. | Semantic Scholar Table 1 from Monitoring unfractionated heparin with the aPTT: time for a fresh look. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fdf15480fd822409aa8e042961075863460e2327/4-Table1-1.png)
Table 1 from Monitoring unfractionated heparin with the aPTT: time for a fresh look. | Semantic Scholar
![Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin Therapy: Issues and Recommendations | Semantic Scholar Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin Therapy: Issues and Recommendations | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2019eac8fb8a0ac9ae460c5e7711983b957e1a3d/2-Table1-1.png)
Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin Therapy: Issues and Recommendations | Semantic Scholar
![Monitoring unfractionated heparin therapy. 4 hour-stability of anti-Xa activity in unspun citrated tubes - Thrombosis Research Monitoring unfractionated heparin therapy. 4 hour-stability of anti-Xa activity in unspun citrated tubes - Thrombosis Research](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/0d9328ad-273c-4f86-b685-80cffbe493a8/gr1_lrg.jpg)
Monitoring unfractionated heparin therapy. 4 hour-stability of anti-Xa activity in unspun citrated tubes - Thrombosis Research
![Accuracy, reproducibility and costs of different laboratory assays for the monitoring of unfractionated heparin in clinical practice: a prospective evaluation study and survey among Swiss institutions | BMJ Open Accuracy, reproducibility and costs of different laboratory assays for the monitoring of unfractionated heparin in clinical practice: a prospective evaluation study and survey among Swiss institutions | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/8/6/e022943/F1.large.jpg)
Accuracy, reproducibility and costs of different laboratory assays for the monitoring of unfractionated heparin in clinical practice: a prospective evaluation study and survey among Swiss institutions | BMJ Open
![Limitations on point care APTT for monitoring of unfractionated heparin in intensive care patients - Thrombosis Research Limitations on point care APTT for monitoring of unfractionated heparin in intensive care patients - Thrombosis Research](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f7b1fbdc-6823-4b84-ae2f-d9ecf6723f9e/gr1_lrg.jpg)
Limitations on point care APTT for monitoring of unfractionated heparin in intensive care patients - Thrombosis Research
![Effects of Pre-analytical Variables on the anti-Xa Chromogenic Assay when Monitoring Unfractionated Heparin and Low Molecular Weight Heparin Anticoagulation. - ppt download Effects of Pre-analytical Variables on the anti-Xa Chromogenic Assay when Monitoring Unfractionated Heparin and Low Molecular Weight Heparin Anticoagulation. - ppt download](https://images.slideplayer.com/25/8040193/slides/slide_2.jpg)
Effects of Pre-analytical Variables on the anti-Xa Chromogenic Assay when Monitoring Unfractionated Heparin and Low Molecular Weight Heparin Anticoagulation. - ppt download
![Anticoagulation Monitoring Part 2: Unfractionated Heparin and Low-Molecular-Weight Heparin | Semantic Scholar Anticoagulation Monitoring Part 2: Unfractionated Heparin and Low-Molecular-Weight Heparin | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c52e0b965c9038f06f9f0c0417e73da157e7579d/7-Table3-1.png)
Anticoagulation Monitoring Part 2: Unfractionated Heparin and Low-Molecular-Weight Heparin | Semantic Scholar
![Pharmacological and clinical evidence for the use of low-molecular-weight heparins in acute coronary syndromes Pharmacological and clinical evidence for the use of low-molecular-weight heparins in acute coronary syndromes](http://www.scielo.br/img/fbpe/abc/v77n2/5325t1.gif)